Baird Reiterates Outperform Rating on Editas Medicine (EDIT) following earnings

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. ENOV
2. AZN
3. MDT
4. BLSM
5. GRMN
6. LTGO
7. TXNM
8. AAPL
9. NXT:AU
10. DK

Go back to Baird Reiterates Outperform Rating on Editas Medicine (EDIT) following earnings
(NASDAQ: EDIT) Delayed: 3.06 --0 (-0%)
Previous Close $3.06    52 Week High $43.99 
Open $3.06    52 Week Low $12.43 
Day High $3.06    P/E N/A 
Day Low $3.06    EPS $0.00 
Volume 2,174